About the Journal

Brief Background

The Revista da Faculdade de Odontologia de Bauru was published from 1993-2002 and was continued in 2003, keeping the numbering of its predecessor with volume 11, number 1 and the new title of Journal of Applied Oral Science.

The Journal of Applied Oral Science publishes volumes in electronic format annually and on a continuous basis.

The main objective of the Journal of Applied Oral Science is to publish the results of original research and, at the invitation of the editor, reviews in the fields of dentistry, speech therapy and related areas.

Its abbreviated title is J. Appl. Oral Sci., which should be used in bibliographies, footnotes and references.

Open Science Compliance

This journal follows the Diamond Open Access model.

Authors must complete and submit the Open Science compliance form with the manuscript. In this form, authors are asked to inform: (a) whether the manuscript is a preprint and, if so, its location; (b) whether data, program codes and other materials underlying the text of the manuscript are properly cited and referenced; and, (c) whether they accept openness options in the peer review process.

Link for the Open Science Compliance form

JAOS is in constant alignment with Open Science practices and, for this reason, adopts a position of permanent improvement and updating of these practices.

In addition to the open access model, JAOS strongly encourages the availability of data and code, allowing the verification and replication of results, promoting transparency and the reproducibility of research.

JAOS encourages preregistration of studies, where applicable, as a practice to increase transparency and reduce publication bias. Preregistration involves recording details of the study, such as hypotheses, methods and analyses, prior to data collection, which helps mitigate adjustments to the analyses based on the results.

JAOS adopts a transparent peer review process in which authors are encouraged to disclose their identities, making the review simple and anonymous. Transparency in the peer review process promotes accountability and the quality of evaluations.

By mutual agreement between reviewers and authors, JAOS may decide in the future to publish the reviews of approved articles with the optional identification of the reviewers.

 

Ethics in Publication

JAOS adopts the principles of publication ethics included in the code of conduct of the Committee on Ethics Publication (COPE).

Allegations of misconduct before and after publication are addressed to the journal and the editor-in-chief and can lead to: removal of the author, a request for a retraction for ethical misconduct, among others.

Authors are obliged to mention their contribution on the title page based on the declaration of authorship according to Contributor Roles Taxonomy (CRediT).

Complaints and appeals should be sent to the journal, editor-in-chief and the JAOS editorial board.

Conflicts of interest of each of the authors, editors and reviewers must be indicated in the article and in the Submission Form. Failure to do so may result in appeals and the need for retraction on the part of those involved.

Data and reproducibility: JAOS encourages the use of clinical and other trial reporting and registration guidelines and the availability of raw data from research published in the journal.

Clinical studies with humans and animals must be approved by a recognized ethics committee. The Plataforma Brasil of the Brazilian National Health Council is suggested for human studies.

JAOS does not accept plagiarism or the like. It considers duplicate or piecemeal publication of the same research to be an ethical breach and is careful to use mechanisms to identify text similarities and detect plagiarism. To check for originality, the article will be checked by the iThenticate software originality detection service. Although the editors make every effort to ensure the validity of published manuscripts, the ultimate responsibility lies with the authors, not JAOS, its editors or reviewers, requiring a retraction from the authors and the article may be withdrawn from publication in the event of subsequent confirmation of plagiarism or misconduct.

Use of Artificial Intelligence - AI

Given that the use of Artificial Intelligence (AI) tools is quite controversial in the scientific writing process, JAOS recommends caution in their use and defines its actions based on the COPE guidelines.

Authors who use Artificial Intelligence tools in the writing of the manuscript, in the production of images or graphic elements of the article, must present in the Methodology section which AI tool was used and how it was employed. Authors are fully responsible for the content of their manuscript, even in parts produced by AI, and are therefore liable for any breach of publication ethics. Authors are advised to use generative artificial intelligence and AI-assisted technologies (e.g. ChatGPT-3, ChatGPT-4) exclusively for the purpose of improving readability and linguistic quality during the writing process. The use of these technologies should be carried out with human supervision and control, and authors should carefully review and edit the content generated, as AI has the potential to produce content that may appear reliable, but may be incorrect, incomplete or biased.

Artificial Intelligence or AI-assisted technologies should not be listed as author or co-author. Authorship implies responsibilities and attributions that can only be carried out by humans.

When using AI or AI-assisted technologies in the writing process, authors will need to include a statement in the “Ethics” section with the following content:

Statement of generative AI and AI-assisted technologies in the writing process: During the preparation of this manuscript, the authors used [NAME OF TOOL / SERVICE] for [REASON]. After using this tool/service, the authors have reviewed and edited the content appropriately and take full responsibility for the content of the publication.

This statement does not apply to the use of basic tools for checking grammar, spelling, references, etc. If there is nothing to communicate, there is no need to add this statement.

 Focus and Scope

JAOS’s mission is to disseminate scientific and technological advances made by the dental and speech and hearing communities, respecting quality indicators in order to ensure their acceptability to researchers in the field. Its main objective is to publish the results of original research in the field of oral sciences, with an emphasis on dentistry, speech therapy and related areas.

Submissions of case reports (including case series and clinical protocols) and short communications are not accepted by JAOS and review manuscripts (including systematic reviews) can only be sent at the invitation of the editor.

 

Digital Preservation

Articles published in JAOS are digitally preserved by the LOCKSS (Lots of Copies Keep Stuff Safe) system offered by SciELO in partnership with the Cariniana Network.

 

Indexing Sources

Bibliographic Journal Information

Journal title: Journal of Applied Oral Science

Short title: J. Appl. Oral Sci.

Published by: Universidade de São Paulo. Faculdade de Odontologia de Bauru.

Frequency: Annual

Type of publication: Continuous publication

Year the journal was created: 2003

 Websites and Social Media

https://www.revistas.usp.br/jaos

https://www.instagram.com/journaljaos/

https://twitter.com/JournalJAOS

https://www.facebook.com/JournalJAOS

 

EDITORIAL POLICY

 Preprints

JAOS is open to submissions of preprints. A preprint is defined as a manuscript ready for submission to a journal that is deposited on trusted servers, prior to or in parallel with submission to a journal. A reliable preprint server needs to have a transparent moderation policy, offer DOI to submitted preprints, allow changes, comments and community evaluation with researcher endorsement and interoperability with other services and platforms. Only submissions of work previously deposited on public server platforms that meet these reliability and transparency characteristics will be accepted.

The public platforms Preprints, SciELO Preprints and EmeRI are recommended for open discussion before approval and publication in the journal.

If the article is accepted and published in JAOS, the authors must update their registration on the preprint server, providing the full reference of the publication in the journal.

Peer Review Process

The peer review process will be in the simple anonymous method, in which the authors do not know the identity of the reviewers, but the reviewers know the identity of the authors. The names of the Editor-in-Chief and Associate Editor will be published in the final version of the article.

Preanalysis: The manuscripts will be submitted to the Editors-in-Chief and Associates for assessment as to their suitability for the scope of the journal, priority and potential impact of publication and citation, degree of novelty and methodology. Manuscripts that do not meet all of these requirements at this stage will be immediately rejected and returned to the authors, while manuscripts deemed appropriate will follow the regular peer review process.

Technical evaluation: Papers approved in the preanalysis stage will be evaluated for compliance with the publication rules and documentation required when submitting manuscripts to JAOS. If they do not comply with the instructions, they will be returned to the authors for adjustments before being submitted for evaluation by the Associate Editors and reviewers. Only after the required documentation has been complied with will the manuscript be assigned by the Editor-in-Chief to an Associate Editor in the manuscript’s main subject area. From this stage onward, the Associate Editor becomes the editor responsible for processing and evaluating the manuscript.

Merit and content analysis: The articles approved by the Associate Editors will be evaluated for merit and scientific method by at least two ad hoc referees from institutions other than the one where the manuscript originated, in addition to the Editor-in-Chief. The evaluators will be able to recommend four options: “accepted,” “reconsider after minor corrections,” “reconsider after extensive corrections,” or “reject the manuscript.”

Decision: The Editor-in-Chief will decide whether to accept the manuscript. If the original needs to be revised, the manuscript will be returned to the corresponding author for modification. A revised version with the changes made and highlighted in the file must be resubmitted by the authors and will be re-evaluated by the Editor-in-Chief, Associate Editor and reviewers, as necessary. When approved, the names of the Editors-in-Chief and Associate Editors will be published in the article.

Approval: Once the papers have been approved for their scientific merit, they will be submitted for a final revision of the English language by a company contracted by JAOS. In cases of disagreement, the papers will be sent back to the authors for revision.

Rejection rate: The percentage of accepted articles is 15%. The 85% of rejections are divided between manuscripts rejected in preanalysis and after peer review.

Time for decision and publication: The average evaluation time for a final decision of approval or rejection is 75 days, varying according to the number of rounds of review. This does not include manuscripts that have been rejected in preanalysis, without peer review. In these cases, the response time is up to 7 calendar days. After acceptance, the estimated time for publication is 40 days.

 

Proofreading

Galley proof of the article will be sent to the corresponding author by e-mail in PDF format for final approval.

The author will have 48 hours to correct and return the original duly revised, if necessary.

Only minor changes, spelling corrections and checking of illustrations will be accepted. Extensive modifications will result in the manuscript being re-examined by the reviewers and a delay in publication.

If the galley proof is not returned within 48 hours, the Editor-in-Chief will consider the unchanged version to be final.

The inclusion of new authors is not allowed at this stage of the publication process.

It is the sole responsibility of the authors to check that their scientific names have been properly used in the manuscript, as well as their affiliations.

Open Data

Research data corresponds to any information that has been observed, collected, generated or created to validate the results of the original research. It includes raw data, processed data, audio, video, code, software, algorithms, protocols and methods. Although usually digital, research data also includes non-digital formats such as laboratory notebooks and diaries.

Where appropriate, authors must ensure that confidential data is not shared in order to preserve ethics, legality and privacy, otherwise consent to disclose the data must be provided by the participants involved. Research data that is not necessary to verify the results reported in articles is not covered by this policy.

The preferred mechanism for sharing research data is through a data repository, which is a relevant tool for authors/collaborators to archive and share organized data from original and processed research with or without supplementary material. It is recommended to encourage good practices by following Open Science to ensure security and transparency.

Among the data repositories recommended by JAOS is the SciELO Data repository. It is an open, fee-free system that allows collaborators to deposit research data associated with a specific manuscript. Using SciELO Data, authors must submit data ONLY after the manuscript has been accepted. JAOS follows the Type 3 Data Policy on Research and adopts Level 1 Content Curation.

A list of recommended repositories for depositing data is available at: https://wp.scielo.org/wp-content/uploads/Lista-de-Repositorios-Recomendados_pt.pdf

To guarantee the quality and recognition of the data generated, JAOS recommends and follows the FAIR principles (Findable, Accessible, Interoperable and Reusable).

Embargoes on data sharing are permitted. When publishing a dataset, the author can choose to postpone the date the data is made available. This means that the description and files of that dataset will not be publicly available until the embargo date is reached. Meanwhile, other information about the dataset, such as the collaborators, the title, the citation and the associated articles are available immediately before the embargo.

Sharing research data in JAOS as Supplementary Material to the submission is not allowed. Authors must have their dataset deposited in recognized repositories.

JAOS encourages authors to cite any publicly available research data in their reference list. References to datasets (data citations) must include a persistent identifier (DOI). Dataset citations, when they appear in the reference list, must include the minimum information recommended by DataCite and follow JAOS style.

Example:

Mahardawi B. The role of hemostatic agents following dental extractions: a systematic review and meta-analysis [dataset]. 2022 Mar 14 [cited 2022 Apr 22]. In: Dryad [Internet]. doi: 10.5061/dryad.59zw3r297. Available from: https://doi.org/10.5061/dryad.59zw3r297

JAOS encourages research data to be made available under open licenses that allow free reuse, and recommends the adoption of the CC BY 4.0 License (Creative Commons Attribution 4.0 International) which authorizes the sharing, use and adaptation of research data as long as credit is given to the authors, but the author can decide which Creative Commons License is the most appropriate for the type of data deposited.

The provision of a Data Availability Statement is a condition of publication and should contain information on where the data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analyzed or generated during the study. When research data is not publicly available, this should be stated in the manuscript along with any conditions for accessing the data. Data Availability Statements usually take one of the following forms:

Data available in a publicly accessible repository

The datasets generated during and/or analyzed during the current study are available in the [NAME] repository, [DOI - PERSISTENT WEB LINK TO DATASETS].

Data available on request due to restrictions, e.g. privacy or ethics

The datasets generated during and/or analyzed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Data sharing not applicable

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Third-party data

The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name]

Questions about compliance with this policy should be sent to jaos@usp.br.

Fees

JAOS operates in the Diamond open access model and there is no charge to authors for submitting or processing articles (APC).

Financial and structural sustainability is divided between the Bauru School of Dentistry, Program for Supporting Scientific Periodicals of the University of São Paulo and SciELO Brasil.

 

Ethics and Misconduct, Correction and Retraction Policy

JAOS endorses the COPE guidelines and will take seriously any allegations of potential misconduct or facts that cast doubt on the integrity of the research to be published. Suspicious cases will be reviewed by the Editors and the parties involved will be contacted. The resolution of the case will follow COPE’s guidelines and directions.

In the event of misconduct, the journal will apply a retraction policy, in accordance with the Guidelines on Best Practices proposed by SciELO.

The Registration and Publication of Erratum will follow the recommendations proposed by SciELO.

The registration and publication of Editorial Retraction will be as proposed by SciELO.

Policy on Conflict of Interest

JAOS is aligned with the guidelines of the International Committee of Medical Journal Editors (ICMJE) and COPE on aspects relating to potential conflicts of interest that may occur in the development of the study. Conflict of interest exists when a primary judgment, for the actual validity of the research, is influenced by a secondary interest, such as financial gain or other benefits. Conflict can also occur when authors, reviewers or editors have interests that influence the preparation and evaluation of the manuscript.

When submitting the manuscript, authors must disclose any activity or relationship that could be perceived as a conflict of interest. This declaration must be included in the Submission Form and will be published in the final version of the approved article.

Editors and reviewers, likewise, should speak up when there is a conflict of interest.

Adoption of Similarity Software

Whether intentional or not, plagiarism will not be tolerated in manuscripts published by JAOS. Such practices include, but are not limited to, copying and reusing text, ideas, images or data from other sources without clear citation to the original source. As part of the evaluation process, all manuscripts, in all rounds of review, will be subjected to analysis by plagiarism software (Crossref Similarity Check, powered by iThenticate). At any stage of the review process, processing or even after publication, if plagiarism is detected, manuscripts may be rejected or retracted.

 

Diversity, Equity, Inclusion and Accessibility (DEIA) - Issues of Sex, Gender and Inclusive Language Use

Diversity, Equity, Inclusion and Accessibility (DEIA) are fundamental elements that must be considered at all stages of the research process.

The JAOS editorial team, as well as the authors who publish in the journal, must always observe the Sex and Gender Equity in Research (SAGER) guidelines. The SAGER guidelines comprise a set of guidelines for reporting sex and gender information in study design, data analysis, results and interpretation of findings. In addition, JAOS observes the gender equity policy in the composition of its editorial board.

The use of inclusive language is fundamental to promoting diversity, equality and accessibility in scientific communication. We encourage authors to adopt language practices that consider and respect diversity of gender, race, age and other characteristics, thus contributing to a more welcoming and equitable academic environment. We recommend following the guidelines set out in the South African Journal of Science’s Inclusive Language Policy.

Ethics Committee, Records and Mandatory Checklists

When the research article involves human beings or animals, the authors must mention the approval number of the ethics committee of the institution responsible in the methodology of the manuscript.

Documents proving approval by the Ethics Committee may be requested during the review process.

Experimental procedures on animals

Articles presenting animal studies must be accompanied by a completed ARRIVE Checklist. The document is available at: https://mc04.manuscriptcentral.com/societyimages/jaos-scielo/ARRIVEChecklist.docx

Registration of trials involving human beings

JAOS supports the clinical trial registration policies of the World Health Organization (OMS) and the International Committee of Medical Journal Editors (ICMJE), recognizing the importance of these initiatives for the registration and international dissemination of open access clinical trials. Therefore, only clinical research articles that have been registered on one of the clinical trial platforms and validated by the criteria established by the WHO and the ICMJE will be accepted for publication.

A clinical trial is any research study that prospectively or retrospectively assigns human participants or groups of humans to one or more health-related interventions to assess health effects and outcomes. Interventions include, but are not restricted to, drugs, cells and other biological products, surgical procedures, radiological procedures, devices, behavioral treatments, changes in the care process, preventive care, etc.

Interventional Clinical Trials

Articles involving interventional clinical trials on human volunteers should be sent with the CONSORT 2010 or SPIRIT checklist.

It is compulsory to enter the registration number of the database search.

Suggestion for Brazilian authors.

Suggestions for Brazilian and non-Brazilian authors (ISRCTN).

Submissions with a registration date later than the date of submission of the article to JAOS will not be accepted.

 Observational Clinical Trials

Articles involving observational clinical trials on human volunteers should be sent with the STROBE checklist.

It is compulsory to provide proof of the search registration number.

Submissions with a registration date later than the date of submission of the article to JAOS will not be accepted.

Questionnaires on human volunteers

Articles involving questionnaires on human volunteers should be sent accompanied by the CHERRIES checklist.

It is compulsory to provide proof of the search registration number.

Submissions with a registration date later than the date of submission of the article to JAOS will not be accepted.

 

Systematic Reviews

Systematic Reviews MUST ONLY BE SUBMITTED AT THE INVITATION OF JAOS. Nonetheless, submissions of Systematic Reviews of any kind (Traditional, Overviews, Umbrella Reviews and Scoping Reviews) will only be received if they meet the following mandatory requirements:

PRISMA 2020 statement checklist duly completed, including all its extensions in particular cases.

PROSPERO International Prospective Register of Systematic Reviews or Open Science Framework

Submissions with a registration date later than the date of submission of the article to JAOS will not be accepted.

The Editor-in-Chief and the Editorial Board reserve the right to reject articles that do not show clear evidence that these principles have been followed or whose methods are considered inappropriate for use in humans or animals.

Other issues will be resolved by the Editor-in-Chief and the editorial board.

Copyright

Authors of articles published by JAOS retain the copyright of their work by licensing it under Creative Commons Attribution, which allows articles to be reused and distributed without restriction, as long as the original source is correctly cited.

Authors grant the journal the right of first publication under the CC BY 4.0 License, which allows access, printing, reading, distribution, remixing, adaptation and development of other works with acknowledgment of authorship.

Intellectual Property and Terms of Use

All the content of the journal and the articles published by JAOS, except where otherwise specified, are licensed under the Creative Commons Attribution license.

JAOS encourages authors to self-archive their accepted manuscripts by publishing them on personal blogs, institutional repositories and academic social media, as well as posting them on their personal social media, as long as the full citation to the journal’s website version is included

JAOS has the right to submit all manuscripts to the Editorial Board, which is authorized to determine the suitability of their content for peer review. Unqualified manuscripts will receive an Immediate Rejection decision.

The content of the texts, citations and references of the papers submitted and published are the sole responsibility of the authors and do not necessarily reflect the opinion of the Editor-in-Chief or Editorial Board.

 

Processing Dates

The dates on which the original article was received, revised and accepted, as well as the names of the Editor-in-Chief and Associate Editor, will be provided in the final published version of the article.

Sponsors and Promotion Agencies

The publication are funded by:

ABCD-USP - Agência de Bibliotecas e Coleções Digitais

Bauru School of Dentistry of the University of São Paulo (FOB-USP)

National Council for Scientific and Technological Development (CNPq) and Coordination for the Improvement of Higher Education Personnel (CAPES)

     

 

EDITORIAL BOARD

Editors-in-Chief

 

Associate Editors

Technical Team

  • José Roberto Plácido Amadei, librarian, – CRB 8ª 7324 – Universidade de São Paulo (USP), Faculdade de Odontologia de Bauru (FOB), Bauru, SP, Brazil, amadei@fob.usp.br, ORCID: https://orcid.org/0000-0001-8748-5132
  • Valéria Cristina Trindade Ferraz, librarian – CRB 8ª 4720 - Universidade de São Paulo (USP), Faculdade de Odontologia de Bauru (FOB), Bauru, SP, Brazil, valeria@fob.usp.br
  • Neimar Vitor Pavarini, journalist – Mtb 25076 - Universidade de São Paulo (USP), Faculdade de Odontologia de Bauru (FOB), Bauru, SP, Brazil, neimar@usp.br
  • Heitor Marques Honório, statistical consultant - Universidade de São Paulo (USP), Faculdade de Odontologia de Bauru (FOB), Bauru, SP, Brazil, heitorhonorio@usp.br

 

INSTRUCTIONS TO AUTHORS

 Types of Documents Accepted

  • Original Articles
  • Review articles (including systematic reviews) at the invitation of the editors
  • Preprints, provided they are available on open, reliable platforms that allow open discussion before publication/acceptance (see Preprints section in the editorial policy)

 

Authors’ Contribution

Authorship should be attributed following the recommendations of the ICMJE: substantial contributions to the conception or design of the study; or collection, analysis, or interpretation of the study data; writing or critical review with important intellectual contribution; final approval of the version to be published; and agreement to take responsibility for all aspects of the work, ensuring that issues related to the accuracy and integrity of any part of the study have been properly investigated and resolved.

All authors must have an ORCID registration (https://orcid.org/) and link it to their ScholarOne registration. See the Authors’ guidelines for guidance on how to link ORCID to your ScholarOne account. They must also be added in step 4 of the submission process in the ScholarOne system.

All authors must describe their participation in the preparation of the manuscript, using the CREDiT taxonomy structure, contained in the Submission Form and also during the submission of the manuscript to ScholarOne.

 

Manuscript Preparation

 

Article Submission Format

Title page

It must be submitted in a separate file from the main file and contain:

a) The title of the manuscript in English.

b) The names of the authors in direct order followed by their institutional affiliation. For Brazilian authors, the affiliations must be in Portuguese, in Spanish for Latin Americans and in English for other nationalities.

Authorship should be attributed following the recommendations of the ICMJE: substantial contributions to the conception or design of the study; or collection, analysis, or interpretation of the study data; writing or critical review with important intellectual contribution; final approval of the version to be published; and agreement to take responsibility for all aspects of the work, ensuring that issues related to the accuracy and integrity of any part of the study have been properly investigated and resolved.

All authors must have an ORCID registration (https://orcid.org/) and link it to their ScholarOne registration. See the Authors’ Guidelines for guidance on how to link ORCID to your ScholarOne account.

All authors must be added in step 4 of the submission process in the ScholarOne system.

All authors must describe their participation in the preparation of the manuscript, using the CREDiT taxonomy structure, contained in the Submission Form and also during the submission of the manuscript to ScholarOne.

c) Full address of the corresponding author, to whom all correspondence will be addressed, including telephone and e-mail address.

d) Information on the deposit of the manuscript on a preprint server, where applicable, indicating the access address and DOI number; citation and referencing of the research data specifying the repository and DOI number. Attach the Open science Complicance

e) Mandatory note informing whether the manuscript is derived from dissertations or theses and the respective access address when available.

 

Main file

The manuscript must have been previously translated or revised into English by a company, freelance professional or authors who are native English speakers.

a) Title of the work in English.

b) A structured abstract of no more than 300 words in a single paragraph, containing the following subsections: brief introduction, objective, methodology, results and conclusions.

c) Keywords: These are the words or expressions that identify the content of the article. To determine the keywords, authors should consult the MeSH and DeCS subject lists. Three to 5 keywords should be added, separated from each other by periods and the first letter of the first word should be capitalized. Ex: Dental implants. Fixed prosthesis. Photoelasticity. Passive fit.

d) Introduction: Summarize the reasoning and proposal of the study, citing only relevant references. Establish the hypothesis of the study.

e) Methodology: The material and methods are presented in sufficient detail to allow the observations to be confirmed. Include the city, state and country of all manufacturers after the first mention of products, instruments, software, equipment, etc. Published methods should be referenced and discussed briefly, unless modifications have been made. Indicate the statistical methods used, if applicable. See the section on ethical principles and registration of clinical trials.

f) Results: Should be presented in a logical sequence in the text, with tables and illustrations. Do not repeat all the data from the tables and illustrations in the text, emphasizing only the important observations.

g) Discussion: Emphasize the new and important aspects of the study in context with observations from previous research. Do not repeat in detail data or information cited in the introduction or results. Point out the implications of your findings and their limitations.

h) Conclusion: Briefly list the conclusions that can be drawn from the research. Do not just restate the results, but establish conclusions that are relevant to the objectives and justified by the data. In most situations, the conclusions are true only for the population of the experiment.

i) Acknowledgments (where appropriate): Thank those who have made a significant contribution to the study (people, laboratories, sectors, etc.).

j) Funding: Specify sponsors, financial aid, scholarships and/or programs, citing the name of the funding organization and the file number.

k) Declarations: Add, after the acknowledgments, if any, declarations of conflict of interest and availability of research data.

l) References (see References section).

Graphical abstract

A graphic abstract is a visual format of the manuscript to summarize the essential findings of the study. It helps to disseminate easy and concise information, which can be quickly incorporated by readers and helps it to be shared, including on social media. JAOS therefore encourages this submission. An original figure that clearly indicates the sequence described in the manuscript needs to be designed (JPEG, minimum 300 dpi and 1080 x 1080 pixels - width x height) and sent as a separate file.

Examples:   

https://www.instagram.com/p/CL44dlbF-wu/
https://www.instagram.com/p/CVh4M9aFsGw/
https://www.instagram.com/p/CHhyixyFkag/

 

Digital Assets

Illustrations (photographs, graphs, drawings, flowcharts, etc.) will be considered as figures in the text, and they should be kept to a necessary minimum and added in separate files, numbered consecutively in Arabic numerals, in the order in which they appear in the text. They must be in .jpg format, with at least 300 dpi resolution and between 15 cm and 20 cm wide.

Materials from digital cameras must have at least 3 megapixels of uncompressed optical resolution (high definition module).

Tables should be logically organized, numbered consecutively in Arabic numerals and the legend should be placed at the top. They must be included in the text of the manuscript.

Illustration captions and table titles should be clear, concise and located at the end of the main file in the form of a separate list and preceded by the corresponding numbering.

Footnotes to illustrations and tables will be indicated by asterisks and kept to a necessary minimum.

 

Citations and References

Authors can be cited in the text in one of two ways:

1) Numerical only - References should be cited in ascending order in the paragraph.

E.g. ... and interfere with the bacterial system and tissue system.3,4,7-10

2) or alphanumeric:

One author: Gatewood31 (2012)

Two authors: Cotti and Mercuro19 (2016)

Three authors: Azar, Safi, Nikaein27 (2012)

More than three authors: Gealh, et al.28 (2014)

 

References

References must comply with the “Uniform requirements for manuscripts submitted to Biomedical Journals - Vancouver.”

All references must be cited in the text. They should be ordered according to their presentation in the text and numbered sequentially in ascending order. The abbreviations of the titles of the journals cited should be in accordance with the MEDLINE standard.

Do not include personal communications and bibliographic material without a publication date in the list of references.

Theses, dissertations, monographs and abstracts will not be accepted as references, even if they have a DOI.

Minimize references to publications in languages other than English. The title translated into English should be cited in square brackets and the original language inserted at the end of the reference.

List the names of the first 6 authors of the work; if this number is exceeded, the first 6 authors of the work should be cited, followed by the expression “et al.” not written in italics and accompanied by a period.

Ex: Cintra LT, Samuel RO, Azuma MM, Ribeiro CP, Narciso LG, Lima VM, et al.

Do not exceed 40 references.

 

 Examples of References

Book

Preedy VR, organizer. Fluorine: chemistry, analysis, function and effects. London: Royal Society of Chemistry; 2015.

Book chapter

Buzalaf CP, Leite AL, Buzalaf MA. Fluoride metabolism. In: Preedy VR, organizer. Fluorine: chemistry, analysis, function and effects. London: Royal Society of Chemistry; 2015. p. 54-72.

Journal article

Conti PC, Bonjardim LR, Stuginski-Barbosa J, Costa YM, Svensson P. Pain complications of oral implants: Is that an issue? J Oral Rehabil. 2021;48(2):195-206. doi: 10.1111/joor.13112

Journal article with original language other than English

Schubert O, Le V, Probst F. Chancen und Risiken von Zahnimplantaten [Dental implants - opportunities and risks]. MMW Fortschr Med. 2022;164(9):50-2. German. doi: 10.1007/s15006-022-0970-4

Journal article exclusively on the Internet (with electronic identifier)

Peixoto KO, Resende CM, Almeida EO, Almeida-Leite CM, Conti PC, Barbosa GA, et al. Association of sleep quality and psychological aspects with reports of bruxism and TMD in Brazilian dentists during the COVID-19 pandemic. J Appl Oral Sci [Internet]. 2021 [cited 2022 June 20];29:e20201089. Available from: http://dx.doi.org/10.1590/1678-7757-2020-108

Journal article with DOI

Francese MM, Gonçalves IV, Vertuan M, Souza BM, Magalhães AC. The protective effect of the experimental TiF4 and chitosan toothpaste on erosive tooth wear in vitro. Sci Rep. 2022;12(1):7088. doi: 10.1038/s41598-022-11261-1

Journal article Epub ahead of print/In press/Forthcoming

Pucciarelli MG, Toyoshima GH, Oliveira TM, Neppelenbroek KH, Soares S. Quantifying the facial proportions in edentulous individuals before and after rehabilitation with complete dentures compared with dentate individuals: a 3D stereophotogrammetry study. J Prosthet Dent. Forthcoming 2022. doi: 10.1016/j.prosdent.2022.03.013

Preprint

Weissheimer T, Só MV, Alcalde MP, Cortez JB, Rosa RA, Vivan RR, et al. Evaluation of mechanical properties of coronal flaring nickel-titanium instruments. Research Square rs-49258/v1 [Preprint]. 2020 [cited 2020 Sept 2]. Available from: https://doi.org/10.21203/rs.3.rs-49258/v1

Research data

Mahardawi B. The role of hemostatic agents following dental extractions: a systematic review and meta-analysis [dataset]. 2022 Mar 14 [cited 2022 Apr 22]. In: Dryad [Internet]. doi: 10.5061/dryad.59zw3r297. Available from: https://doi.org/10.5061/dryad.59zw3r297

Artificial intelligence

ChatPDF GmbH. What is the significance of beta-defensin 118 in the defense against Candida infection? [artificial intelligence]. GPT-3.5 version 2023 [cited 2023 Oct 19]. Available from: https://www.chatpdf.com/

Articles with more than 6 authors:

Cite up to the first 6 followed by the expression “et al.”

Bergantin BT, Di Leone CC, Cruvinel T, Wang L, Buzalaf MA, Borges AB, et al. S-PRG-based composites erosive wear resistance and the effect on surrounding enamel. Sci Rep. 2022;12(1):833. doi: 10.1038/s41598-021-03745-3

Volume with supplement and/or special issue

Ricomini AP Filho, Chávez BA, Giacaman RA, Frazão P, Cury JA. Community interventions and strategies for caries control in Latin American and Caribbean countries. Braz Oral Res. 2021;35(suppl 1):e054. doi: 10.1590/1807-3107bor-2021.vol35.0054

The accuracy of the references is the responsibility of the authors.                  

 

Supplementary Documents

The Submision Form, signed by ALL authors, must be submitted as a mandatory file.

The Open Science Complicance form MUST be submitted as a mandatory file.

 

Additional Information

Manuscripts should be submitted to: https://mc04.manuscriptcentral.com/jaos-scielo

 

Contact

Journal of Applied Oral Science

Faculdade de Odontologia de Bauru - USP

Alameda Dr. Octávio Pinheiro Brisolla, 9-75

CEP: 17012-901 – Bauru – São Paulo – Brazil

Tel.: (55 14) 3235-8373

E-mail: jaos@usp.br